dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· January 22, 2026

Procter & Gamble posts earnings beat: CFO on the results

View original at finance.yahoo.com
Procter & Gamble posts earnings beat: CFO on the results Procter & Gamble (PG) reported adjusted earnings of $1.88 per share and revenue of $22.2 billion for its fiscal second quarter…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • US had weak shipment quarter due to significant inventory build in base year from two port strikes and hurricane about a year ago

    80% confidence
  • Tariff exposure reduced from $1 billion at beginning of year to $400 million after tax

    80% confidence
  • P&G consumption in US over last three months would have been 1.5% to 2% in value terms excluding pantry loading

    80% confidence
  • Gillette is one of P&G's most profitable businesses from an operating margin perspective

    80% confidence
  • Innovation capabilities across biology, chemistry, fiber technology, assembled products, and electronics have never been stronger

    80% confidence
  • P&G reduced tariff exposure through productivity work, sourcing changes, formulation changes, and innovation-based pricing

    80% confidence
  • If base effect of inventory loading is removed, US would have already shown growth

    80% confidence
  • Typical category growth rate is 3-4%, and current 1-2% growth is slower than normal

    80% confidence
  • P&G firmly believes categories will return to 3-4% growth over time

    80% confidence
  • P&G offers three tiers of diapers: Swaddlers (super premium), Baby Dry (mid-tier), and Luvs (value tier close to private label pricing)

    80% confidence
  • P&G categories in US have grown between 1-2% in value growth and flat in volume growth over past three months

    80% confidence
  • Six figure jobs are being created from AI data centers

    80% confidence
  • US economy is growing at 4-5% and could continue at that growth rate

    80% confidence
  • Business outside the US is growing 3% with Latin America at 8%, China at 3%, Europe at 3%, and Asia/Africa at 2%

    80% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Procter & Gamble posts earnings beat: CFO on the results: Source | Via News | fr.via.news